Results 201 to 210 of about 1,161,134 (263)

Design of a novel epitope-based tetravalent subunit vaccine against dengue virus: An immunoinformatic approach. [PDF]

PLoS One
Ferdousy TJ, Hasan Miraz MM, Al Arian T, Afif Ullah M, Risat MTH, Akter MA, Kundu S, Sarkar BK, Sarkar AP, Khalipha ABR, Kundu SK.   +10 more
europepmc   +1 more source

Modeling the effects of vector species composition and temperature on the risk of dengue virus. [PDF]

Bull Math Biol
Robertson SL, de Jesús Crespo R, Beck E, Beuerle L, Martin P, Stambaugh R, Robert MA.   +6 more
europepmc   +1 more source

Antiviral agents for dengue virus. [PDF]

Virol Sin
Jiang Y, Wang Y, Xu Y, Tian Y, Zhao M, Shen C, Yang Y, Yang M.   +7 more
europepmc   +1 more source

Therapeutic approaches against dengue virus: current status of vaccines, antivirals, and monoclonal antibodies. [PDF]

Emerg Microbes Infect
Bouzidi HS, De Lamballerie X, Touret F.
europepmc   +1 more source

Variation in virulence of dengue virus

The Lancet, 1999
openaire   +2 more sources

Clinical and Analytical Performance of the AP Biotech Discovery^® Dengue Virus RT-PCR Detection Kit. [PDF]

Viruses
Hjelt V, Dronseck A, Schey AM, Martí MB, Civerchia L, Cavatorta AL, Codino E, Nader V, Garro NA, Aranda FM, Mammana L, Giamperetti S, Theaux C, Marchissio A, Burani VE, Luczak EN, Bellucci MM, García G, Cayrol F, Bouzas MB, Grutadauria S, Brocardo L.   +21 more
europepmc   +1 more source

Outbreak of Dengue Virus Serotype 3, Republic of the Marshall Islands, 2019-2021. [PDF]

Emerg Infect Dis
León TM, McCready J, Chutaro E, McAllister J, Solomon B, Hapairai LK.   +5 more
europepmc   +1 more source

Multi-district molecular surveillance of dengue virus in Pakistan reveals serotype cycling and recurrent DENV-2 dominance, 2021-2025. [PDF]

PLoS One
Umair M, Hakim R, Jamal Z, Ali Q, Salman M.   +4 more
europepmc   +1 more source